Compared with maternal vaccination with the RSVpreF (respiratory syncytial virus prefusion F) protein vaccine, infant immunization with nirsevimab is associated with a lower risk of RSV-related hospitalization, researchers… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
